Amneal Pharmaceuticals
Logotype for Amneal Pharmaceuticals Inc

Amneal Pharmaceuticals (AMRX) investor relations material

Amneal Pharmaceuticals Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Amneal Pharmaceuticals Inc
Q4 2025 earnings summary27 Feb, 2026

Executive summary

  • Achieved sixth consecutive year of growth, with 2025 revenue up 8% to $3.02 billion and adjusted EPS up 43%, meeting or exceeding all guidance metrics.

  • Q4 2025 revenue reached $814 million (+11%), adjusted EBITDA $175 million (+13%), and adjusted EPS $0.21 (+75%).

  • Specialty segment growth driven by CREXONT® for Parkinson's and Brekiya® autoinjector for migraine; Affordable Medicines expanded with robust new product launches.

  • Debt refinancing reduced interest costs, extended maturities to 2032, and improved net leverage to 3.5x.

  • Strategic collaboration with Pfizer on GLP-1s and new manufacturing facilities progressing well.

Financial highlights

  • FY2025 net revenue: $3.02 billion (+8%), adjusted EBITDA: $688 million (+10%), adjusted EPS: $0.83 (+43%).

  • Q4 2025 net revenue: $814 million (+11%), adjusted EBITDA: $175 million (+13%), adjusted EPS: $0.21 (+75%).

  • Operating cash flow for 2025: $340 million; capital expenditures: $89 million.

  • Net leverage improved to 3.5x from 3.9x year-over-year.

  • AvKARE segment gross margin rose over 400 basis points in 2025, with operating income up 65% year-over-year.

Outlook and guidance

  • 2026 revenue guidance: $3.05–$3.15 billion (+1%–4%), adjusted EBITDA $720–$760 million (+5%–10%), adjusted EPS $0.93–$1.03 (+12%–24%).

  • Affordable Medicines expected to grow 7%–8% in 2026; Specialty segment flat due to RYTARY® competition; AvKARE revenue projected at $625–$700 million.

  • 2026 adjusted gross margin expected to exceed 44%, with operating cash flow of $325–$400 million and CapEx of ~$110 million.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.

Next Amneal Pharmaceuticals earnings date

Logotype for Amneal Pharmaceuticals Inc
Barclays 28th Annual Global Healthcare Conference10 Mar, 2026
Amneal Pharmaceuticals
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Amneal Pharmaceuticals earnings date

Logotype for Amneal Pharmaceuticals Inc
Barclays 28th Annual Global Healthcare Conference10 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Amneal Pharmaceuticals, Inc. is a pharmaceutical company engaged in the development, manufacturing, and distribution of generic and specialty pharmaceutical products. The company offers a wide range of dosage forms, including oral solids, injectables, and topicals, addressing therapeutic areas such as central nervous system disorders, oncology, and cardiovascular conditions. The company is headquartered in Bridgewater, New Jersey, and its shares are listed on the NYSE.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage